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New sources of hematopoietic stem cells (HSCs) are now being explored world-wide, scientific societies have changed their names, and both the latest authoritative multiauthor texts, Barrett and Treleaven published in 1998 and this one published in 1999, have abandoned the classical emphasis on bone marrow as the source of stem cells in order to take account of other potential sources. In this book there is no doubt that the chapters by Metcalf on human hematopoiesis and Lansdorp on stem self-renewal are both stimulating and rewarding. It is a pity that they had no chance to give their views on the unexpected hematopoietic potential demonstrated by adult neural stem cells reported recently in the columns of Science which has amazed many of us! 1 It is obviously impossible to review critically even a small proportion of the chapters in this magnificent volume. Suffice it to say that each of the original chapters have been substantially updated, and there is now a wealth of entirely new contributions which will interest biologists and clinicians. I was particularly fascinated by the chapters on tolerance (Sykes-Strober) and mixed chimerism (Storb-YuMcSweeney), the latter outlining the rationale for the exciting new concept of non-myeloablative stem cell allotransplantation. However, as one of the proponents of intensive immunosuppression for severe autoimmune diseases, followed by allogeneic or autologous HSCs, I personally doubt whether achieving mixed chimerism will prevent resensitization to autoantigens and so ensure 'cure', as proposed in this section. Other outstandingly exciting chapters are on cord blood usage (Broxmeyer-Smith) and in utero transplantation (Flake-Zanjani). All the clinical sections, both on allogeneic and autologous HSC transplants, are upto-date and with no exceptions excellent, and all of them make good reading both for experts and tyros. It is indeed encouraging to learn that even advanced AL amyloidosis, a hitherto devastating disease, may consistently respond to high-dose melphalan followed by autologous HSC support (Comenzo).
Entire new sections have been devoted to autologous HSC transplantation in solid tumors, such as breast, smallcell lung, germ cell, ovarian, brain, neuroblastoma and other solid tumors. Non-malignant diseases are discussed in depth, with an especially fascinating chapter on Fanconi anemia (Wagner-Davies-Auerbach).
Transplantation of organs or cells must be seen as a 'bridge' that should permit the clinician to control potentially fatal diseases in the hope that more reliable biologically based treatments will eventually be developed. In the final chapter Ernest Beutler, after having taught us about 'Polystems' and the drugs TetraP (glorified SCF) and Thromboproliferin (but it is already here!), predicts that in the 21st or 22nd century transplantation will be required no more. Sure. But in the meantime this book will help contemporary HSC transplanters to widen their knowledge and, hopefully, to improve their clinical results. 
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